Historical Stock Price
RGLS historical stock prices picture
Regulus Therapeutics (RGLS) has the following price history information. Looking back at RGLS historical stock prices for the last five trading days, on March 22, 2024, RGLS opened at $2.80, traded as high as $2.84 and as low as $2.56, and closed at $2.69. Trading volume was a total of 697.90K shares. On March 25, 2024, RGLS opened at $2.70, traded as high as $2.99 and as low as $2.67, and closed at $2.82. Trading volume was a total of 1.08M shares. On March 26, 2024, RGLS opened at $2.84, traded as high as $3.00 and as low as $2.67, and closed at $2.85. Trading volume was a total of 832.90K shares. On March 27, 2024, RGLS opened at $2.88, traded as high as $3.00 and as low as $2.73, and closed at $2.88. Trading volume was a total of 887.00K shares. On March 28, 2024, RGLS opened at $2.81, traded as high as $2.93 and as low as $2.80, and closed at $2.88. Trading volume was a total of 809.00K shares.

RGLS Historical Stock Prices By Date:

RGLS historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Regulus Therapeutics shares, starting with a $10,000 purchase of RGLS, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/01/2014
End date: 03/28/2024
Start price/share: $1,030.80
End price/share: $2.88
Dividends collected/share: $0.00
Total return: -99.72%
Average Annual Total Return: -44.47%
Starting investment: $10,000.00
Ending investment: $27.92
Years: 10.00
Date Open High Low Close Volume
03/22/2024 $2.80 $2.84 $2.56 $2.69 697.90K
03/25/2024 $2.70 $2.99 $2.67 $2.82 1.08M
03/26/2024 $2.84 $3.00 $2.67 $2.85 832.90K
03/27/2024 $2.88 $3.00 $2.73 $2.88 887.00K
03/28/2024 $2.81 $2.93 $2.80 $2.88 809.00K
Regulus Therapeutics is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs to treat diseases. Co.'s key product candidates are RG-012 and RGLS4326. RG-012 is an anti-miR targeting miR-21 for the treatment of Alport syndrome, a life-threatening kidney disease. RGLS4326 is an anti-miR targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease. Co. has multiple programs in various stages of preclinical development including RGLS5579 as a clinical candidate in its glioblastoma multiforme program, its preclinical programs targeting the Hepatitis B virus and Non-Alcoholic Steatohepatitis program.
Date Close
03/22/2024$2.69
03/25/2024$2.82
03/26/2024$2.85
03/27/2024$2.88
03/28/2024$2.88
RGLS is categorized under the Healthcare sector; below are some other companies in the same sector:

RGNX Historical Stock Prices
RHE Historical Stock Prices
RIGL Historical Stock Prices
RIOT Historical Stock Prices
RLYP Historical Stock Prices
RMD Historical Stock Prices
RMTI Historical Stock Prices
RNN Historical Stock Prices
RNVA Historical Stock Prices
RNVAZ Historical Stock Prices

Also explore: RGLS shares outstanding history

Email EnvelopeFree RGLS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


RGLS Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.